DBCO-PEG4 amine

Catalog No. :
ACLAEC217
CAS No. :
1255942-08-5
Molecular Formula :
C29H37N3O6
Molecular Weight :
523.63

IUPAC Name:DBCO-PEG-NH2, MW 20,000

DBCO-PEG4 amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg95%$70.00Login to see priceIn stockInquiry
25mg95%$140.00Login to see priceIn stockInquiry
50mg95%$238.00Login to see priceIn stockInquiry
100mg95%$404.00Login to see priceIn stockInquiry
250mg95%$686.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDBCO-PEG4 amine
IUPAC NameDBCO-PEG-NH2, MW 20,000
MDL No.0
Molecular FormulaC29H37N3O6
Molecular Weight523.63
SMILESO=C(CCOCCOCCOCCOCCN)NCCC(N1C2=C(C#CC3=C(C1)C=CC=C3)C=CC=C2)=O
InChI KeyKTIOBJVNCOFWCL-UHFFFAOYSA-N
SynonymDBCO-PEG4-amine;Azadibenzocyclooctyne-PEG4-amine;DBCO-NH-PEG4-CH2CH2NH2;DBCO-PEG4-NH2;3-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethoxy]-N-[3-(2-azatricyclo[10.4.0.04,9]hexadeca-1(16),4,6,8,12,14-hexaen-10-yn-2-yl)-3-oxopropyl]propanamide;DBCO-PEG4 amine (ADIBO-PEG4-amine);DBCO-NHCOPEG4-amine;DBCO-NHCO-PEG4-amine TFA salt
CAS No.1255942-08-5
PubChem CID86580489

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLAEC217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDJKT435 route compound structure diagram
    ACDJKT4351255942-12-1 In Stock
  2. Then
  3. ACLAEC217 route product structure diagram
    ACLAEC2171255942-08-5 In Stock
Inquiry

2. ACLAEC217 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLAEC217 route product structure diagram
    ACLAEC2171255942-08-5 In Stock
Inquiry

Comments (0)